Decatur Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-52,728
| Closed | -$3.52M | – | 66 |
|
|
2021
Q2 | $3.52M | Buy |
52,728
+84
| +0.2% | +$5.61K | 1.1% | 28 |
|
|
2021
Q1 | $3.32M | Sell |
52,644
-47,338
| -47% | -$2.99M | 1.15% | 29 |
|
|
2020
Q4 | $6.2M | Sell |
99,982
-2,175
| -2% | -$135K | 1.14% | 32 |
|
|
2020
Q3 | $6.16M | Buy |
102,157
+19,101
| +23% | +$1.15M | 1.21% | 31 |
|
|
2020
Q2 | $4.88M | Buy |
83,056
+2
| +0% | +$118 | 1.29% | 28 |
|
|
2020
Q1 | $4.63M | Sell |
83,054
-21,311
| -20% | -$1.19M | 1.55% | 18 |
|
|
2019
Q4 | $6.7M | Sell |
104,365
-1,338
| -1% | -$85.9K | 1.53% | 20 |
|
|
2019
Q3 | $5.36M | Sell |
105,703
-41,025
| -28% | -$2.08M | 1.32% | 35 |
|
|
2019
Q2 | $6.65M | Sell |
146,728
-3,325
| -2% | -$151K | 1.25% | 38 |
|
|
2019
Q1 | $7.16M | Buy |
150,053
+18
| +0% | +$859 | 1.38% | 36 |
|
|
2018
Q4 | $7.8M | Buy |
150,035
+28,100
| +23% | +$1.46M | 1.75% | 23 |
|
|
2018
Q3 | $7.57M | Sell |
121,935
-30,300
| -20% | -$1.88M | 1.74% | 24 |
|
|
2018
Q2 | $8.43M | Sell |
152,235
-925
| -0.6% | -$51.2K | 1.67% | 26 |
|
|
2018
Q1 | $9.69M | Sell |
153,160
-4,540
| -3% | -$287K | 2% | 21 |
|
|
2017
Q4 | $9.66M | Sell |
157,700
-24,775
| -14% | -$1.52M | 1.96% | 25 |
|
|
2017
Q3 | $11.6M | Buy |
182,475
+10,550
| +6% | +$672K | 2.23% | 14 |
|
|
2017
Q2 | $9.58M | Buy |
+171,925
| New | +$9.58M | 2.01% | 24 |
|